Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds.
By Shankuan Zhu, Zimian Wang, S. Heshka, Moonseong Heo, M. Faith, Steven B. Heymsfield. American Journal of Clinical Nutrition, 2002
736 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Physiology
View Paper: https://www.semanticscholar.org/paper/d244196d4d7eb30006f000fd8f0cb10ca1b6ab30
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
In Physiology
Citations in the corpus
- Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans (2007, background): “Accordingly, waist circumference, which correlates with visceral fat mass (3), has been recommended as a clinical marker to identify patients at increased risk for metabolic diseases (4), and large waist circumference is one of the criteria used to diagnose the metabolic syndrome (5).”
- Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. (2005, background): “et al (22) recommended cutoffs of 90 cm for men and 83 cm for women.”
- Metabolic syndrome: definitions and controversies (2011, background): “Clinical implications for pediatric MetS MetS as a concept was originally developed to identify adults at a greatest risk for CVD and DMT2, however, the application of this model has not yet been fully validated in children and adolescents.”
- Appropriate waist circumference cutoff points for central obesity in Korean adults. (2007, background): “Another recent study on central obesity in Westerners found different sets of WC values associated with increased risk for cardiovascular disease at the designated BMI values: 90 cm for men and 83 cm for women at 25 kg/m2 BMI, and 100 cm for men and 93 cm for women at 30 kg/m2 BMI [21].”
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis (2009, background): “In addition, WC measurements were considered to be the better risk predictor for type II diabetes, hypertension, coronary artery disease, congestive heart failure, stroke and gallbladder disease [16-24].”
- Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. (2005, methodology): “9 to be equivalent to a waist circumference of 102 cm, similar to analysis using data from a large US survey.(30) We have therefore used a BMI of 28.”
- International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006, background): “should enable a comparison of these 2 metrics of obesity.(25-28) Furthermore, the thresholds at which obesity is linked”
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. (2010, result): “All statistical analyses were carried out in SPSS 15.0.0 for Windows (SPSS Inc., Chicago, IL, USA).”